BJDX Bluejay Diagnostics, Inc.

$4.44 -1.33%

Healthcare · Surgical & Medical Instruments & Apparatus

Bluejay Diagnostics, Inc. (BJDX) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $5 million. Shares last traded at $4.44, 47.1% below their 52-week high. Over the past year the stock is up 158.1%. Net profit margin is -2750.0%, below the peer median of -7.6%.

Market Cap

$5M

Shares Out

1.0M

EPS (TTM)

$-23.97

P/E Ratio

—

P/S Ratio

18.45

P/B Ratio

1.10

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.39

52-Week Low

$0.63

Volume

832

Avg Vol (3m)

22,601.587

Performance

-6.33%

+164.29%

+138.71%

+279.49%

YTD

+570.19%

+158.14%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

61.91

SMA (50)

$2.63

SMA (200)

$1.91

Price vs SMA50

+68.66%

Price vs SMA200

+132.53%

ATR (14)

$0.60

Financials

Revenue

$0M

Net Income

$-7M

Gross Margin

19.6%

Operating Margin

-2791.9%

Net Margin

-2750.0%

Return on Equity

-163.8%

Return on Assets

-122.3%

Current Ratio

2.81

Debt / Equity

0.34

Revenue Growth (YoY)

—

Latest reported annual period ending 2022-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-1.95	2026-05-07
FY 2025	$-15.25	2026-03-06
Q3 2025	$-4.62	2025-11-07
Q2 2025	$-3.94	2025-08-07
Q1 2026	$-13.46	2026-05-07
FY 2025	$-456.75	2026-03-06

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

BJDX vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

18.45 / 2.52 med

+633% premium

Net margin vs peers

-2750.0% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.